(Q67865636)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:992711%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

title

Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved B (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:992711%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

author name string

M. R. Daha

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A992711

12 August 2022

D. T. Fearon

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A992711

12 August 2022

K. F. Austen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A992711

12 August 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=992711

12 August 2022

publication date

1 November 1976

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:992711%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

18 September 2019

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/992711/?tool=EBI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A992711

12 August 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:992711%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:992711%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:992711%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

page(s)

789-796

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:992711%20AND%20SRC:MED&resulttype=core&format=json

Properdin: initiation of alternative complement pathway

18 September 2019

cites work

1 reference

12 December 2020

Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor

1 reference

12 December 2020

Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase

1 reference

12 December 2020

C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase

1 reference

12 December 2020

Isolation of alternative pathway C3 convertase containing uncleaved B and formed in the presence of C3 nephritic factor (C3neF)

1 reference

12 December 2020

Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose

1 reference

12 December 2020

The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena

1 reference

12 December 2020

The properdin system and immunity. XIII. Assay and properties of a heat-labile serum factor (factor B) in the properdin system

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

C3 proactivator convertase and its mode of action

1 reference

12 December 2020

A stoichiometric assay for the fourth component of complement in whole human serum using EAC'la-gp and functionally pure human second component.

1 reference

12 December 2020

Serum C'3 lytic system in patients with glomerulonephritis

1 reference

12 December 2020

Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement

1 reference

12 December 2020

Properdin factor D. II. Activation to D by properdin

1 reference

12 December 2020

The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator

1 reference

12 December 2020

Inactivator of the Third Component of Complement as an Inhibitor in the Properdin Pathway

1 reference

12 December 2020

C3b inactivator of man. 3. Further purification and production of antibody to C3b INA

1 reference

12 December 2020

The alternate pathway of complement activation. The role of C3 and its inactivator (KAF)

1 reference

12 December 2020

Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3)

1 reference

12 December 2020

The role of properdin in the alternate pathway of complement activation

1 reference

12 December 2020

Properdin factor D: characterization of its active site and isolation of the precursor form

1 reference

12 December 2020

Enharncement of the hemolytic activity of the second component of human complement by oxidation

1 reference

12 December 2020

C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3

1 reference

12 December 2020

Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum

1 reference

12 December 2020

Initiation of C3 cleavage in the alternative complement pathway

1 reference

12 December 2020

Identifiers

PMC publication ID

1445153

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=992711

12 August 2022

1 reference